معرفی
Santa Ašmane serves as an Assistant Professor in the Department of Neurology and Neurosurgery, specializing in clinical epilepsy research with emphasis on pharmacological interventions for neurological disorders. Her work bridges neurology and pharmaceutical sciences to address critical treatment gaps in seizure management.
Her research program centers on antiepileptic drug development, particularly investigating eslicarbazepine acetate monotherapy for newly diagnosed focal epilepsy. Key focus areas include long-term safety profiling, tolerability assessment, noninferiority trial design, and controlled-release formulation efficacy. This work directly informs clinical practice guidelines for optimal seizure control with minimized adverse effects.
Her 2020 Epilepsia publication represents a significant contribution to evidence-based epilepsy treatment, demonstrating sustained therapeutic benefits through rigorous open-label extension methodology. The study has achieved notable academic impact with 10 Scopus citations and substantial real-world engagement including policy references and social media dissemination.
Professional engagement includes active collaboration through the BIA-2093-311/EXT Investigators Study Group and sustained membership in key professional organizations:
- Latvian Neurophysiology Society (2017-2020)
- Latvian Epilepsy Society (2017-2020)
